Ascendis Pharma A (ASND) Interest Coverage Ratio (2014 - 2026)
Ascendis Pharma A (ASND) posted Interest Coverage Ratio of 0.37 for Q1 2026, up 131.06% sequentially from 0.16 in Q4 2025, and down 84.15% YoY from 2.33 in Q1 2025.
Ascendis Pharma A (ASND) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Ascendis Pharma A has reported Interest Coverage Ratio for 13 years, with the latest figure at 0.37 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 84.15% year-over-year to 0.37 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02 (down 100.0% YoY) and the FY2025 annual result came in at 0.66, up 76.34% from the prior year.
- Interest Coverage Ratio grew to 0.37 in Q1 2026 per ASND's latest filing, from 0.16 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 478.53 in Q4 2022 and troughed at 29461538.46 in Q4 2024.
- A 5-year average of 1733008.91 and a median of 3.82 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio slumped 677993512.51% in 2024, then soared 465.34% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 478.53 in 2022, then slumped by 100.91% to 4.35 in 2023, then plunged by 677993512.51% to 29461538.46 in 2024, then surged by 100.0% to 0.16 in 2025, then jumped by 131.06% to 0.37 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.37, 0.16, and 0.16 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | -0.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.37 |
| Dec 31, 2025 | 0.16 |
| Sep 30, 2025 | 0.16 |
| Jun 30, 2025 | -1.60 |
| Mar 31, 2025 | 2.33 |
| Dec 31, 2024 | -29.46 Mn |
| Sep 30, 2024 | -3.82 |
| Jun 30, 2024 | -6.79 |
| Mar 31, 2024 | -0.64 |
| Dec 31, 2023 | -4.35 |
| Sep 30, 2023 | -5.48 |
| Jun 30, 2023 | -15.09 |
| Mar 31, 2023 | -14.60 |
| Dec 31, 2022 | 478.53 |
| Sep 30, 2022 | -3.50 |
| Jun 30, 2022 | -15.04 |
| Mar 31, 2022 | -23.71 |
| Dec 31, 2021 | 287.93 |
| Sep 30, 2021 | -110.53 |
| Jun 30, 2021 | -9.69 |